Business Context and Reporting Period
Company: Mustang Bio, Inc. (MBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: November 18, 2022 (Event Date: November 22, 2022)
Reporting Period: This filing addresses a specific corporate event regarding stock listing status rather than a financial reporting period.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing focuses exclusively on regulatory compliance regarding stock listing requirements.
Material Changes
- Listing Tier Transfer: Nasdaq approved the transfer of the Company's common stock from The Nasdaq Global Market to The Nasdaq Capital Market, effective November 25, 2022.
- Grace Period Extension: The Company was granted a second 180-calendar day period to regain compliance with the $1.00 minimum bid price requirement.
- Compliance Deadline: The Company must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days by May 22, 2023.
Outlook, Risks, and Management Commentary
- Management Intent: The Company intends to monitor the closing bid price and consider all available options to remedy the deficiency.
- Delisting Risk: If compliance is not demonstrated by May 22, 2023, the Company faces potential delisting notification.
- Appeal Process: In the event of a delisting notification, the Company may appeal, which would stay the delisting action pending a hearing before the Nasdaq Hearings Panel.
- Trading Impact: The transfer of listing tiers is not expected to impact trading; the stock will continue to trade under the symbol "MBIO."
Investor Verification Checklist
- Verify the current closing bid price of MBIO stock relative to the $1.00 threshold.
- Monitor the stock's performance to ensure it meets the 10 consecutive business day requirement before the May 22, 2023 deadline.
- Review subsequent filings for any updates on the Company's strategy to address the bid price deficiency.
- Confirm the effective date of the listing transfer (November 25, 2022) and any associated trading changes.